FOXO3: at the crossroads of metabolic, inflammatory, and tumorigenic remodeling in the colon

Am J Physiol Gastrointest Liver Physiol. 2024 Mar 1;326(3):G247-G251. doi: 10.1152/ajpgi.00201.2023. Epub 2024 Jan 9.

Abstract

The Forkhead box O3 (FOXO3) transcription factor regulates the expression of genes critical for diverse cellular functions in homeostasis. Diminished FOXO3 activity is associated with human diseases such as obesity, metabolic diseases, inflammatory diseases, and cancer. In the mouse colon, FOXO3 deficiency leads to an inflammatory immune landscape and dysregulated molecular pathways, which, under various insults, exacerbates inflammation and tumor burden, mimicking characteristics of human diseases. This deficiency also results in dysregulated lipid metabolism, and consequently, the accumulation of intracellular lipid droplets (LDs) in colonic epithelial cells and infiltrated immune cells. FOXO3 and LDs form a self-reinforcing negative regulatory loop in colonic epithelial cells, neutrophils, and macrophages, which is associated with inflammatory bowel disease and colon cancer, particularly in the context of obesity.

Keywords: FOXO3; colon cancer; inflammatory bowel disease; lipid droplets; obesity.

Publication types

  • Review

MeSH terms

  • Animals
  • Colonic Neoplasms* / metabolism
  • Forkhead Box Protein O3 / genetics
  • Forkhead Box Protein O3 / metabolism
  • Forkhead Transcription Factors* / metabolism
  • Humans
  • Mice
  • Obesity

Substances

  • Forkhead Box Protein O3
  • Forkhead Transcription Factors
  • FOXO3 protein, human